According to Pacific Biosciences 's latest financial reports the company's current earnings (TTM) are -$0.3 B. In 2021 the company made an earning of -$0.28 B a decrease over its 2020 earnings that were of $29.4 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | -$0.3 B | 8.42% |
2021 | -$0.28 B | -1034.84% |
2020 | $29.4 M | -134.95% |
2019 | -$84.14 M | -17.97% |
2018 | -$0.11 B | 11.25% |
2017 | -$92.19 M | 23.95% |
2016 | -$74.38 M | 134.65% |
2015 | -$31.7 M | -52.09% |
2014 | -$66.16 M | -16.56% |
2013 | -$79.3 M | -15.99% |
2012 | -$94.39 M | -14.01% |
2011 | -$0.11 B | -21.65% |
2010 | -$0.15 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $7.92 B | -2,759.57% | ๐บ๐ธ USA |
![]() General Electric GE | $3.15 B | -1,157.32% | ๐บ๐ธ USA |
![]() Illumina ILMN | -$4.06 B | 1,259.65% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $0.83 B | -380.48% | ๐บ๐ธ USA |
![]() Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
![]() NanoString Technologies NSTG | -$0.14 B | -54.11% | ๐บ๐ธ USA |